Options
Expression of the Alzheimer’s Disease Mutations AβPP695sw and PSEN1M146I in Double-Transgenic Göttingen Minipigs
ISSN
1875-8908
1387-2877
Date Issued
2016
Author(s)
Jakobsen, Jannik E.
Johansen, Marianne G.
Schmidt, Mette
Liu, Ying
Li, Rong
Callesen, Henrik
Melnikova, Margarita
Habekost, Mette
Matrone, Carmela
Nielsen, Anders Lade
Duthie, Monika
Fraser, Paul E.
Holm, Ida E.
Jørgensen, Arne Lund
DOI
10.3233/JAD-160408
Abstract
Mutations in the amyloid-beta protein precursor gene (A beta PP), the presenilin 1 gene (PSEN1) or the presenilin 2 gene (PSEN2) that increase production of the A beta PP-derived peptide A beta(42) cause early-onset Alzheimer's disease. Rodent models of the disease show that further increase in A beta(42) production and earlier brain pathology can be obtained by coexpressing A beta PP and PSEN1 mutations. To generate such elevated A beta(42) level in a large animal model, we produced Gottingen minipigs carrying in their genome one copy of a human PSEN1 cDNA with the Met146Ile (PSEN1M146I) mutation and three copies of a human A beta PP695 cDNA with the Lys670Asn/Met671Leu (A beta PPsw) double-mutation. Both transgenes were expressed in fibroblasts and in the brain, and their respective proteins were processed normally. Immunohistochemical staining with A beta(42)-specific antibodies detected intraneuronal accumulation of A beta(42) in brains from a 10- and an 18-month-old pig. Such accumulation may represent an early event in the pathogenesis of Alzheimer's disease.